X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24047) 24047
Publication (1522) 1522
Newspaper Article (805) 805
Book Review (375) 375
Book Chapter (164) 164
Conference Proceeding (68) 68
Magazine Article (60) 60
Trade Publication Article (35) 35
Dissertation (18) 18
Book / eBook (7) 7
Paper (3) 3
Web Resource (3) 3
Data Set (2) 2
Government Document (2) 2
Journal / eJournal (2) 2
Archival Material (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15823) 15823
molecular-weight heparin (7946) 7946
female (6967) 6967
index medicus (6908) 6908
molecular weight (6408) 6408
male (6126) 6126
anticoagulants - therapeutic use (5026) 5026
heparin, low-molecular-weight - therapeutic use (4829) 4829
heparin (4369) 4369
animals (4334) 4334
hematology (4074) 4074
middle aged (3845) 3845
aged (3452) 3452
adult (3427) 3427
peripheral vascular disease (3308) 3308
anticoagulants (3219) 3219
venous thromboembolism (3171) 3171
thrombosis (2939) 2939
risk factors (2928) 2928
deep-vein thrombosis (2906) 2906
unfractionated heparin (2889) 2889
thromboembolism (2638) 2638
prevention (2589) 2589
surgery (2443) 2443
anticoagulants - administration & dosage (2405) 2405
anticoagulants - adverse effects (2269) 2269
heparin, low-molecular-weight - administration & dosage (2225) 2225
treatment outcome (2094) 2094
heparin - therapeutic use (2005) 2005
low molecular weight heparin (1988) 1988
pregnancy (1879) 1879
enoxaparin (1851) 1851
medicine, general & internal (1807) 1807
heparin, low-molecular-weight - adverse effects (1670) 1670
pharmacology & pharmacy (1610) 1610
fibrinolytic agents - therapeutic use (1523) 1523
prophylaxis (1502) 1502
venous thrombosis (1484) 1484
low-molecular-weight heparin (1469) 1469
heparin - pharmacology (1458) 1458
pulmonary-embolism (1452) 1452
venous thrombosis - prevention & control (1421) 1421
thromboembolism - prevention & control (1379) 1379
cardiac & cardiovascular systems (1364) 1364
aged, 80 and over (1352) 1352
heparin - adverse effects (1337) 1337
cancer (1324) 1324
pulmonary embolism (1283) 1283
rats (1251) 1251
anticoagulation (1247) 1247
biochemistry & molecular biology (1233) 1233
risk (1214) 1214
postoperative complications - prevention & control (1208) 1208
venous thrombosis - drug therapy (1198) 1198
drug therapy (1189) 1189
venous thromboembolism - prevention & control (1180) 1180
warfarin (1179) 1179
care and treatment (1158) 1158
heparin, low-molecular-weight - pharmacology (1158) 1158
prospective studies (1145) 1145
time factors (1126) 1126
therapy (1119) 1119
retrospective studies (1114) 1114
heparin - administration & dosage (1105) 1105
hemorrhage - chemically induced (1062) 1062
anticoagulants - pharmacology (1031) 1031
glycosaminoglycans (1020) 1020
research (1017) 1017
analysis (1011) 1011
thromboprophylaxis (1000) 1000
dose-response relationship, drug (967) 967
health aspects (924) 924
management (882) 882
mortality (872) 872
proteins (868) 868
risk assessment (852) 852
mice (846) 846
medicine & public health (841) 841
thrombosis - prevention & control (839) 839
aspirin (838) 838
oncology (832) 832
venous thrombosis - etiology (818) 818
risk-factors (800) 800
abridged index medicus (794) 794
kinetics (793) 793
diagnosis (790) 790
pulmonary embolism - prevention & control (787) 787
blood coagulation - drug effects (784) 784
randomized controlled trials as topic (772) 772
adolescent (767) 767
thrombocytopenia - chemically induced (758) 758
enoxaparin - therapeutic use (737) 737
deep vein thrombosis (736) 736
deep venous thrombosis (736) 736
complications (732) 732
incidence (723) 723
acute coronary syndromes (709) 709
factor xa inhibitors (706) 706
low-molecular-weight (694) 694
patients (692) 692
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22471) 22471
German (906) 906
French (720) 720
Spanish (201) 201
Russian (169) 169
Chinese (116) 116
Japanese (94) 94
Polish (94) 94
Czech (50) 50
Hungarian (35) 35
Italian (35) 35
Danish (27) 27
Swedish (24) 24
Dutch (23) 23
Korean (21) 21
Portuguese (21) 21
Turkish (21) 21
Norwegian (18) 18
Bulgarian (15) 15
Finnish (11) 11
Croatian (9) 9
Slovak (9) 9
Slovenian (7) 7
Hebrew (5) 5
Serbian (5) 5
Ukrainian (4) 4
Lithuanian (3) 3
Romanian (2) 2
Bosnian (1) 1
Icelandic (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/1991, Volume 324, Issue 22, pp. 1565 - 1574
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 04/2017, Volume 2017, Issue 4, p. CD007557
Background Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction presenting as a prothrombotic disorder related to antibody-mediated platelet... 
Thrombosis [etiology; prevention & control] | ED AMERICAN-COLLEGE | Thrombocytopenia [chemically induced, complications | RISK-FACTORS | Humans | Heparin [administration & dosage; adverse effects] | DEEP-VEIN THROMBOSIS | prevention & control | PATIENTS ANTITHROMBOTIC THERAPY | ANTIBODY-FORMATION | Postoperative Complications [chemically induced | Randomized Controlled Trials as Topic | Heparin, Low-Molecular-Weight [administration & dosage; adverse effects] | MEDICINE, GENERAL & INTERNAL | Anticoagulants [administration & dosage; adverse effects] | VENOUS THROMBOEMBOLISM | PORCINE HEPARIN | HIP-REPLACEMENT | HEMORRHAGIC COMPLICATIONS | CRITICALLY-ILL PATIENTS | Venous Thrombosis [etiology; prevention & control] | Anticoagulants - administration & dosage | Postoperative Complications - prevention & control | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Surgical Procedures, Operative - statistics & numerical data | Thrombocytopenia - chemically induced | Anticoagulants - adverse effects | Heparin - adverse effects | Thrombocytopenia - complications | Venous Thrombosis - etiology | Numbers Needed To Treat | Thrombosis - etiology | Thrombocytopenia - prevention & control | Venous Thrombosis - prevention & control | Heparin, Low-Molecular-Weight - administration & dosage | Thrombosis - prevention & control | Postoperative Complications - chemically induced
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 07/2007, Volume 5, Issue 7, pp. 1373 - 1379
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 252 - 261
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2016, Volume 67, Issue 21, pp. 2519 - 2532
Heparin-induced thrombocytopenia is a profoundly dangerous, potentially lethal, immunologically mediated adverse drug reaction to unfractionated heparin or,... 
antithrombin agents | cardiopulmonary bypass | bivalirudin | anticoagulant agents | argatroban | platelets | CARDIAC & CARDIOVASCULAR SYSTEMS | FACTOR 4/HEPARIN ANTIBODIES | CORONARY-ARTERY-BYPASS | CRITICALLY III PATIENTS | CARDIAC-SURGERY | MOLECULAR-WEIGHT HEPARIN | MICROPARTICLE GENERATION ASSAY | OF-THE-LITERATURE | DIRECT THROMBIN INHIBITORS | OPEN-HEART-SURGERY | Polysaccharides - therapeutic use | Recombinant Proteins - therapeutic use | Platelet Transfusion | Antithrombins - therapeutic use | Humans | Pipecolic Acids - pharmacokinetics | Risk Factors | Peptide Fragments - pharmacokinetics | Recombinant Proteins - pharmacokinetics | Thrombocytopenia - chemically induced | Cardiopulmonary Bypass | Anticoagulants - adverse effects | Antithrombins - pharmacokinetics | Heparin - adverse effects | Incidence | Plasmapheresis | Pipecolic Acids - therapeutic use | Platelet Function Tests | Thrombocytopenia - diagnosis | Peptide Fragments - therapeutic use | Thrombocytopenia - therapy | Hirudins - pharmacokinetics | Percutaneous Coronary Intervention | Thrombocytopenia | Transluminal angioplasty | Enzymes | Catheterization | Medical societies | Immunoglobulin G | Thrombin | Thrombosis | Risk factors | Blood clot | Complications and side effects | Coronary artery bypass | Heparin | Enzyme-linked immunosorbent assay | Heart attacks | Blood platelets | Heart surgery | Laboratories | Embolisms | Mortality | Gangrene | Bone surgery | Patients
Journal Article